Trial intelligence / Profile preview

Effects of testosterone on glycaemic control and cardiovascular risk factors in hypogonadal men with uncontrolled type 2 diabetes

2011-006114-14Phase 4Unknown

Sponsor
Research and Development department
Start
Apr 2012
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in Hypogonadism and type 2 diabetes mellitus (T2DM) comparing Nebido add-on with Placebo add-on (2 arms). Primary endpoints: HbA1c and fasting plasma glucose. Status: unknown.

02

Drugs

testosterone undecanoate
03

Conditions

Hypogonadismtype 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2011-006114-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-006114-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call